Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.

Gao W, Chan JY, Wong TS.

Clin Sci (Lond). 2014 Nov;127(9):571-9. doi: 10.1042/CS20140010.

PMID:
24896104
2.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

3.

A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.

Leotta M, Biamonte L, Raimondi L, Ronchetti D, Di Martino MT, Botta C, Leone E, Pitari MR, Neri A, Giordano A, Tagliaferri P, Tassone P, Amodio N.

J Cell Physiol. 2014 Dec;229(12):2106-16. doi: 10.1002/jcp.24669.

PMID:
24819167
4.

The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.

Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG.

Int J Biochem Cell Biol. 2012 Dec;44(12):2321-32. doi: 10.1016/j.biocel.2012.08.006. Epub 2012 Aug 10.

PMID:
22903020
5.

MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.

Liu N, Tang LL, Sun Y, Cui RX, Wang HY, Huang BJ, He QM, Jiang W, Ma J.

Cancer Lett. 2013 Feb 28;329(2):181-8. doi: 10.1016/j.canlet.2012.10.032. Epub 2012 Nov 8.

PMID:
23142282
6.

MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.

Jiang L, Huang Q, Chang J, Wang E, Qiu X.

Exp Lung Res. 2011 Sep;37(7):387-98. doi: 10.3109/01902148.2010.492068. Epub 2011 Jul 21.

PMID:
21777146
7.

Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.

Xu Y, Huang Z, Liu Y.

Mol Med Rep. 2014 Nov;10(5):2601-8. doi: 10.3892/mmr.2014.2567. Epub 2014 Sep 15.

PMID:
25231560
8.

miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.

Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G.

Carcinogenesis. 2013 Feb;34(2):415-25. doi: 10.1093/carcin/bgs329. Epub 2012 Oct 24.

PMID:
23097559
9.

An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J, Li G.

BMC Med Genomics. 2012 Jan 19;5:3. doi: 10.1186/1755-8794-5-3.

10.

miR-200b suppresses cell growth, migration and invasion by targeting Notch1 in nasopharyngeal carcinoma.

Yang X, Ni W, Lei K.

Cell Physiol Biochem. 2013;32(5):1288-98. doi: 10.1159/000354527. Epub 2013 Nov 22.

11.

Expression of microRNAs in basal cell carcinoma.

Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

Br J Dermatol. 2012 Oct;167(4):847-55. doi: 10.1111/j.1365-2133.2012.11022.x. Epub 2012 Aug 20.

PMID:
22540308
12.

miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.

Zhang Q, Li Q, Xu T, Jiang H, Xu LG.

Oncol Rep. 2016 Jun;35(6):3541-7. doi: 10.3892/or.2016.4713. Epub 2016 Mar 29.

PMID:
27035429
13.

MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.

Liu N, Jiang N, Guo R, Jiang W, He QM, Xu YF, Li YQ, Tang LL, Mao YP, Sun Y, Ma J.

Mol Cancer. 2013 Oct 20;12(1):123. doi: 10.1186/1476-4598-12-123.

14.

MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.

Qin X, Wan Y, Wang S, Xue M.

Drug Des Devel Ther. 2015 Dec 24;10:71-9. doi: 10.2147/DDDT.S93104. eCollection 2016.

15.

MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.

Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M.

Clin Cancer Res. 2011 May 1;17(9):2725-33. doi: 10.1158/1078-0432.CCR-10-2132. Epub 2011 Jan 10.

16.

MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma.

Liu Y, Li Z, Wu L, Wang Z, Wang X, Yu Y, Zhao Q, Luo F.

Cancer Cell Int. 2014 Mar 7;14(1):24. doi: 10.1186/1475-2867-14-24.

17.

Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.

Wang F, Lu J, Peng X, Wang J, Liu X, Chen X, Jiang Y, Li X, Zhang B.

J Exp Clin Cancer Res. 2016 Jan 22;35:17. doi: 10.1186/s13046-016-0292-4.

18.

Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.

Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, Chang YG, Shen Q, Park WS, Lee JY, Borlak J, Nam SW.

Hepatology. 2013 Mar;57(3):1055-67. doi: 10.1002/hep.26101. Epub 2013 Feb 11.

PMID:
23079745
19.

Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.

Ye M, Zhang J, Zhang J, Miao Q, Yao L, Zhang J.

Cancer Lett. 2015 Feb 1;357(1):196-205. doi: 10.1016/j.canlet.2014.11.028. Epub 2014 Nov 18.

PMID:
25444916
20.

MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.

Yang W, Lan X, Li D, Li T, Lu S.

BMC Cancer. 2015 Jun 9;15:461. doi: 10.1186/s12885-015-1464-x.

Supplemental Content

Support Center